Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ --Â Halia Therapeutics, Inc., a clinical-stage biopharmaceutical…
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc.…
Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation
WALTHAM, Mass., Oct. 15, 2025 /PRNewswire/ -- We are proud to announce…
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
October 09, 2025 07:00 ET Â | Source: Axsome Therapeutics, Inc. NEW YORK,…
ORYZON to Participate in Upcoming Events in September and October
September 25, 2025 08:00 ET Â | Source: Oryzon Genomics, S.A. MADRID and…
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
September 16, 2025 17:10 ET Â | Source: Theratechnologies MONTREAL, Sept. 16, 2025…
Avicanna Announces Change in CFO
September 12, 2025 18:00 ET Â | Source: Avicanna Inc. TORONTO, Sept. 12,…
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 12, 2025 07:00 ET Â | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass.,…
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage…
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
September 02, 2025 21:33 ET Â | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…